HPLC method development for fampridine using Analytical Quality by Design approach

Abstract

Offering a systematic and multivariate analysis of the analytical procedure, development and validation of HPLC methods using Quality by Design approach are in the limelight of current research trends. A new, experimental design-aided HPLC method for fampridine was developed and preliminarily validated according to current in-force international guidelines for linearity, accuracy, robustness and precision. The method offers a high throughput sample analysis, with an elution time of 2.9 minutes, and signal detection without excipient interference performed at 262 nm. The method proved to be linear between 1-15 μg mL-1 (R2= 0.9996). The mean recovery was found to be 98.7 ± 1.9 % in the tested range of 2.5-7.5 μg mL-1. Low RSD values (< 1 %) were obtained for both model, intra- A nd inter-day precision. The limit of detection and limit of quantification were 0.24 and 0.78 μg mL-1, resp. The method proved to be applicable for active substance assay in a pharmaceutical dosage form.